Scientific breakthroughs do not happen in isolation. As
@NoubarAfeyan reflects in his
@FlagshipPioneer 2026 Annual Letter, they require sustained investment in the conditions and technologies that make new therapeutic approaches possible.
One
#MiracleInTheMaking at Sail is recognizing early that moving beyond chronic disease management would require a fundamentally different approach to how RNA medicines are designed and delivered.
By integrating the design of eRNA™ molecules with targeted delivery for our vanguard in vivo CAR-T program, we can shift treatment paradigms toward durable, remission-like outcomes in severe autoimmune disease.
#FlagshipFounded #JPM26 #MiraclesInTheMaking